165 related articles for article (PubMed ID: 24209905)
1. Mapping the interactome of overexpressed RAF kinase inhibitor protein in a gastric cancer cell line.
Gu H; Zhan X; Zhang G; Yan L; Cho WC; Li M; Liu T; Chen Z
BMC Cancer; 2013 Nov; 13():536. PubMed ID: 24209905
[TBL] [Abstract][Full Text] [Related]
2. RKIP and 14-3-3ε exert an opposite effect on human gastric cancer cells SGC7901 by regulating the ERK/MAPK pathway differently.
Yan L; Gu H; Li J; Xu M; Liu T; Shen Y; Chen B; Zhang G
Dig Dis Sci; 2013 Feb; 58(2):389-96. PubMed ID: 22899242
[TBL] [Abstract][Full Text] [Related]
3. RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN.
Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B
Tumour Biol; 2014 Dec; 35(12):11949-58. PubMed ID: 25172097
[TBL] [Abstract][Full Text] [Related]
4. RKIP expression associated with gastric cancer cell invasion and metastasis.
Jia B; Liu H; Kong Q; Li B
Tumour Biol; 2012 Aug; 33(4):919-25. PubMed ID: 22246605
[TBL] [Abstract][Full Text] [Related]
5. RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway.
Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B
Tumour Biol; 2015 Mar; 36(3):1445-53. PubMed ID: 25547433
[TBL] [Abstract][Full Text] [Related]
6. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.
Zhang XM; Zhou C; Gu H; Yan L; Zhang GY
Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233
[TBL] [Abstract][Full Text] [Related]
7. Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.
Lei X; Chang L; Ye W; Jiang C; Zhang Z
Int J Clin Exp Pathol; 2015; 8(11):14214-20. PubMed ID: 26823735
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
9. Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance.
Chen Y; Lian G; Ou G; Yang K; Chen J; Li H; Chen S; Li J; Zeng L; Huang K
Gastric Cancer; 2016 Apr; 19(2):392-402. PubMed ID: 25764514
[TBL] [Abstract][Full Text] [Related]
10. The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro.
Hao C; Wei S; Tong Z; Li S; Shi Y; Wang X; Zhu ZH
Tumour Biol; 2012 Aug; 33(4):1159-67. PubMed ID: 22373584
[TBL] [Abstract][Full Text] [Related]
11. Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression.
Zhao D; Ma J; Shi J; Cheng L; Li F; Jiang X; Jiang H
Oncol Rep; 2013 Jul; 30(1):304-12. PubMed ID: 23674108
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
[TBL] [Abstract][Full Text] [Related]
13. Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer.
Nisimova L; Wen S; Cross-Knorr S; Rogers AB; Moss SF; Chatterjee D
Crit Rev Oncog; 2014; 19(6):469-81. PubMed ID: 25597356
[TBL] [Abstract][Full Text] [Related]
14. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells.
Lee HC; Tian B; Sedivy JM; Wands JR; Kim M
Gastroenterology; 2006 Oct; 131(4):1208-17. PubMed ID: 17030190
[TBL] [Abstract][Full Text] [Related]
15. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.
Yeung KC; Rose DW; Dhillon AS; Yaros D; Gustafsson M; Chatterjee D; McFerran B; Wyche J; Kolch W; Sedivy JM
Mol Cell Biol; 2001 Nov; 21(21):7207-17. PubMed ID: 11585904
[TBL] [Abstract][Full Text] [Related]
16. Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2.
Deiss K; Kisker C; Lohse MJ; Lorenz K
J Biol Chem; 2012 Jul; 287(28):23407-17. PubMed ID: 22610096
[TBL] [Abstract][Full Text] [Related]
17. Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study.
Dai H; Chen H; Liu W; You Y; Tan J; Yang A; Lai X; Bie P
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2107-17. PubMed ID: 27444299
[TBL] [Abstract][Full Text] [Related]
18. RKIP inhibits the malignant phenotypes of gastric cancer cells.
Zhang XM; Gu H; Yan L; Zhang GY
Neoplasma; 2013; 60(2):196-202. PubMed ID: 23259789
[TBL] [Abstract][Full Text] [Related]
19. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
Kim SO; Kim MR
Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
[TBL] [Abstract][Full Text] [Related]
20. Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.
Beshir AB; Ren G; Magpusao AN; Barone LM; Yeung KC; Fenteany G
Cancer Lett; 2010 Dec; 299(2):137-49. PubMed ID: 20855151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]